Table of Contents
ISRN Oncology
Volume 2011, Article ID 526384, 6 pages
http://dx.doi.org/10.5402/2011/526384
Research Article

Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: National Cancer Institute, Mexico City, Mexico

1Department of Surgical Oncology, National Cancer Institute, San Fernando No. 22 Colonia Seccion XVI, Tlalpan, 14080 Mexico City, DF, Mexico
2Department of Medical Oncology, National Cancer Institute, San Fernando No. 22 Colonia Seccion XVI, Tlalpan, 14080 Mexico City, DF, Mexico
3Department of Critical Care Medicine, National Cancer Institute, San Fernando No. 22 Colonia Seccion XVI, Tlalpan, 14080 Mexico City, DF, Mexico

Received 23 May 2011; Accepted 20 June 2011

Academic Editors: T. S. Ganesan and F. Kuhnel

Copyright © 2011 Horacio N. López-Basave et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Horacio N. López-Basave, Flavia Morales-Vásquez, J. M. Ruiz Molina, et al., “Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: National Cancer Institute, Mexico City, Mexico,” ISRN Oncology, vol. 2011, Article ID 526384, 6 pages, 2011. https://doi.org/10.5402/2011/526384.